Cargando…

Strategies of the War on Cancer: To Kill or to Neutralize?

Detalles Bibliográficos
Autor principal:	Lichtenstein, Anatoly V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335948/ https://www.ncbi.nlm.nih.gov/pubmed/30687641 http://dx.doi.org/10.3389/fonc.2018.00667

Ejemplares similares

Domesticating Cancer: An Evolutionary Strategy in the War on Cancer
por: van Niekerk, Gustav, et al.
Publicado: (2017)

The War on Cancer: Lessons from the War on Terror
por: Huang, Sui
Publicado: (2014)

The War on Cancer: A Military Perspective
por: Oronsky, Bryan, et al.
Publicado: (2015)

Cancer risk in Vietnam war veterans from the Korean Vietnam war veterans’ health study cohort
por: Lee, Wanhyung, et al.
Publicado: (2023)

Glioblastoma Stem-Like Cells, Metabolic Strategy to Kill a Challenging Target
por: Garnier, Delphine, et al.
Publicado: (2019)

Treatment for Moral Injury: Impact of Killing in War
por: Burkman, Kristine, et al.
Publicado: (2022)

Chemotherapy and Oncolytic Virotherapy: Advanced Tactics in the War against Cancer
por: Nguyen, Andrew, et al.
Publicado: (2014)

Cancer Wars: Significance of Protein Unfolding in Cancer and Its Inhibition with Natural Amphiphilic Substances
por: Lipinski, Boguslaw
Publicado: (2014)

War and oncology: cancer care in five Iraqi provinces impacted by the ISIL conflict
por: Skelton, Mac, et al.
Publicado: (2023)

GZ17-6.02 kills prostate cancer cells in vitro and in vivo
por: Booth, Laurence, et al.
Publicado: (2022)

Fingolimod Augments Monomethylfumarate Killing of GBM Cells
por: Dent, Paul, et al.
Publicado: (2020)

Depolarization Controls TRAIL-Sensitization and Tumor-Selective Killing of Cancer Cells: Crosstalk with ROS
por: Suzuki-Karasaki, Yoshihiro, et al.
Publicado: (2014)

Corrigendum: Fingolimod Augments Monomethylfumarate Killing of GBM Cells
por: Dent, Paul, et al.
Publicado: (2020)

Axitinib and HDAC Inhibitors Interact to Kill Sarcoma Cells
por: Roberts, Jane L., et al.
Publicado: (2021)

Size Does Matter: Why Polyploid Tumor Cells are Critical Drug Targets in the War on Cancer
por: Coward, Jermaine, et al.
Publicado: (2014)

The Clone Wars – Revenge of the Metastatic Rogue State: The Sarcoma Paradigm
por: Spraker, Holly L., et al.
Publicado: (2012)

ROS Accumulation by PEITC Selectively Kills Ovarian Cancer Cells via UPR-Mediated Apoptosis
por: Hong, Yoon-Hee, et al.
Publicado: (2015)

Kill and Clearance in HCC: An Approach Based on NK Cells and Macrophages
por: Mehrabi, Maryam, et al.
Publicado: (2021)

The Solidarity and Health Neutrality of Physicians in War & Peace
por: Burkle, Frederick M., et al.
Publicado: (2017)

Radiation for hematologic malignancies: from cell killing to immune cell priming
por: Dabaja, Bouthaina, et al.
Publicado: (2023)

Methylseleninic Acid Sensitizes Ovarian Cancer Cells to T-Cell Mediated Killing by Decreasing PDL1 and VEGF Levels
por: Nair, Deepika, et al.
Publicado: (2018)

Obatoclax kills anaplastic thyroid cancer cells by inducing lysosome neutralization and necrosis
por: Champa, Devora, et al.
Publicado: (2016)

Bovine Milk Lactoferrin Selectively Kills Highly Metastatic Prostate Cancer PC-3 and Osteosarcoma MG-63 Cells In Vitro
por: Guedes, Joana P., et al.
Publicado: (2018)

Phosphodiesterase Type 5 Inhibitors Synergize Vincristine in Killing Castration-Resistant Prostate Cancer Through Amplifying Mitotic Arrest Signaling
por: Hsu, Jui-Ling, et al.
Publicado: (2020)

DNA Double-Strand Break Repair as Determinant of Cellular Radiosensitivity to Killing and Target in Radiation Therapy
por: Mladenov, Emil, et al.
Publicado: (2013)

Can Targeting Hypoxia-Mediated Acidification of the Bone Marrow Microenvironment Kill Myeloma Tumor Cells?
por: Gastelum, Gilberto, et al.
Publicado: (2021)

On evolutionary origin of cancer
por: Lichtenstein, Anatoly V
Publicado: (2005)

Cancer: evolutionary, genetic and epigenetic aspects
por: Lichtenstein, Anatoly V.
Publicado: (2010)

GZ17-6.02 and Doxorubicin Interact to Kill Sarcoma Cells via Autophagy and Death Receptor Signaling
por: Booth, Laurence, et al.
Publicado: (2020)

GZ17-6.02 Interacts With [MEK1/2 and B-RAF Inhibitors] to Kill Melanoma Cells
por: Booth, Laurence, et al.
Publicado: (2021)

Corrigendum: GZ17-6.02 and Doxorubicin Interact to Kill Sarcoma Cells via Autophagy and Death Receptor Signaling
por: Booth, Laurence, et al.
Publicado: (2021)

Tumor-specific T cell-mediated upregulation of PD-L1 in myelodysplastic syndrome cells does not affect T-cell killing
por: Ferrari, Valentina, et al.
Publicado: (2022)

War within a war: The challenges of providing gynecologic cancer care in the besieged Tigray region of northern Ethiopia
por: Teka, Hale, et al.
Publicado: (2022)

The hydrophilic extract from a new tomato genotype (named DHO) kills cancer cell lines through the modulation of the DNA damage response induced by Campthotecin treatment
por: Barone, Daniela, et al.
Publicado: (2023)

GZ17-6.02 and Pemetrexed Interact to Kill Osimertinib-Resistant NSCLC Cells That Express Mutant ERBB1 Proteins
por: Booth, Laurence, et al.
Publicado: (2021)

Phosphodiesterase Type 5 (PDE5) Inhibitors Sensitize Topoisomerase II Inhibitors in Killing Prostate Cancer Through PDE5-Independent Impairment of HR and NHEJ DNA Repair Systems
por: Chang, Jo-Fan, et al.
Publicado: (2019)

Digital strategies in the global war on myopia
por: Tham, Yih-Chung, et al.
Publicado: (2023)

β-Lapachone Selectively Kills Hepatocellular Carcinoma Cells by Targeting NQO1 to Induce Extensive DNA Damage and PARP1 Hyperactivation
por: Zhao, Wenxiu, et al.
Publicado: (2021)

Heat Shock Proteins and HSF1 in Cancer
por: Cyran, Anna M., et al.
Publicado: (2022)

Canine Cancer: Strategies in Experimental Therapeutics
por: Thamm, Douglas H.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_76plr54kcml39cnvsu8eh92gqk